Cargando…
Glucose metabolism determines resistance of cancer cells to bioenergetic crisis after cytochrome-c release
Many anticancer drugs activate caspases via the mitochondrial apoptosis pathway. Activation of this pathway triggers a concomitant bioenergetic crisis caused by the release of cytochrome-c (cyt-c). Cancer cells are able to evade these processes by altering metabolic and caspase activation pathways....
Autores principales: | Huber, Heinrich J, Dussmann, Heiko, Kilbride, Seán M, Rehm, Markus, Prehn, Jochen H M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
European Molecular Biology Organization
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3094064/ https://www.ncbi.nlm.nih.gov/pubmed/21364572 http://dx.doi.org/10.1038/msb.2011.2 |
Ejemplares similares
-
Metabolic Targeting of Breast Cancer Cells With the 2-Deoxy-D-Glucose and the Mitochondrial Bioenergetics Inhibitor MDIVI-1
por: Lucantoni, Federico, et al.
Publicado: (2018) -
Real-time single cell analysis of Smac/DIABLO release during apoptosis
por: Rehm, Markus, et al.
Publicado: (2003) -
Single-cell time-lapse imaging of intracellular O(2) in response to metabolic inhibition and mitochondrial cytochrome-c release
por: Düssmann, Heiko, et al.
Publicado: (2017) -
Ketone body β-hydroxybutyrate (BHB) preserves mitochondrial bioenergetics
por: Llorente-Folch, I., et al.
Publicado: (2023) -
Effect of TP53 deficiency and KRAS signaling on the bioenergetics of colon cancer cells in response to different substrates: A single cell study
por: Kealey, James, et al.
Publicado: (2022)